Related Articles
Targeting the neurokinin-1 receptor inhibits growth of human colon cancer cells
Aprepitant inhibits the progression of esophageal squamous cancer by blocking the truncated neurokinin‑1 receptor
Truncated neurokinin‑1 receptor is an ubiquitous antitumor target in hepatoblastoma, and its expression is independent of tumor biology and stage
The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer
Anti‑inflammatory actions of gabapentin and pregabalin on the substance P‑induced mitogen‑activated protein kinase activation in U373 MG human glioblastoma astrocytoma cells